Clinical Trials Browser

Withdrawn × Everolimus × Gastrointestinal × Clear all

NCT01864070 2014-07-22

Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease

Phase 1 Withdrawn

EndocrineGastrointestinalNET

Liver Neoplasms, Neuroendocrine Tumors